The Medicines and Healthcare products Regulatory Agency (MHRA) then approved tirzepatide for the same purpose in November 2023
In the STEP trials, participants receiving semaglutide showed significant reductions in liver fat measured by MRI imaging, with some studies reporting 40% decreases in hepatic steatosis
In research settings, Semaglutide (10mg) is often treated as an analyte or reference material used to explore mechanistic questions, assay development, or stability behavior under specific storage and handling conditions
At Womens Wellness of Mississippi, we specialize in guiding women through this stage of life with care thats personal, evidence-based, and local
Ultimately, choosing between these two powerful medications comes down to a conversation with your doctor about balancing the potential for results with your own tolerance for side effects
Longer-duration randomized controlled trials with hard clinical endpoints including liver-related morbidity and mortality are essential to definitively establish the clinical value of incretin-based therapies in MASH
.webp)
